Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Transdermal Patch Market 2022
The global transdermal patch market is set to increase by US$ 2.6 billion from 2022 to 2028, representing a compound annual growth rate (CAGR) of 4.8% during the forecast period.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for transdermal patch. The global transdermal patch market is segmented on the basis of type, application, and region. On the basis of type, the global transdermal patch market has been segmented into single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, others. Among these, the matrix segment was accounted for the highest revenue generator in 2021. By application, the global transdermal patch market has been segmented into pain management, smoking cessation aid, overactive bladder (OAB), hormonal therapy, others. The pain management segment is estimated to account for the largest share of the global transdermal patch market. In terms of geography, the global transdermal patch market has been segmented into North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global transdermal patch market in 2021 and is anticipated to hold its share during the forecast period.
The global transdermal patch market is highly competitive. Top players covered in Global Transdermal Patch Market Study are 3M Company, Henan Lingrui Pharmaceutical Ltd, Luye Pharma Group Ltd., Novartis AG, Purdue Pharma Manufacturing LP, Samyang Biopharmaceuticals Corp. (Samyang Holdings Corporation), Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the transdermal patch market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Type: single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, others
Application: pain management, smoking cessation aid, overactive bladder (OAB), hormonal therapy, others
Region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Key Benefits for Stakeholders
– Get a comprehensive picture of the global transdermal patch market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Transdermal patch market overview
Part 3. Market breakdown by type
– Single-layer drug-in-adhesive
– Multi-layer drug-in-adhesive
Part 4. Market breakdown by application
– Pain management
– Smoking cessation aid
– Overactive bladder (OAB)
– Hormonal therapy
Part 5. Market breakdown by region
– North America
– MEA (Middle East and Africa)
– Latin America
Part 6. Key companies
– 3M Company
– Henan Lingrui Pharmaceutical Ltd
– Luye Pharma Group Ltd.
– Novartis AG
– Purdue Pharma Manufacturing LP
– Samyang Biopharmaceuticals Corp. (Samyang Holdings Corporation)
– Teikoku Seiyaku Co., Ltd.
– Teva Pharmaceutical Industries, Ltd.
– Viatris, Inc.